Insider · CIK 0001495328

Galson Steven K

Reports to the SEC for 2 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001495328

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+15.3K sh	—	—	27,794
2026-06-11	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+33.5K sh	—	—	33,540
2025-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.5K sh	—	—	24,991
2025-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+27.2K sh	—	—	27,181
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+6,820 sh	—	—	36,431
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+49.9K sh	—	—	49,933
2024-05-13	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Director	PPurchase	+21.9K sh	$5.49	+$120K	51,551
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+16.7K sh	—	—	29,611
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+39.1K sh	—	—	39,072
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.9K sh	—	—	12,866
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,022
2021-09-01	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionA Award	Director	AAward	+60K sh	—	—	60,000
2013-06-20	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2012-06-14	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2011-06-16	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2010-07-01	VNDAVanda Pharmaceuticals Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2010-07-01	VNDAVanda Pharmaceuticals Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Jun 154
Galson Steven K0000882796-26-000053
SEC(opens sec.gov)
Jun 164
Galson Steven K0001171843-25-003912
SEC(opens sec.gov)
Jun 144
Galson Steven K0001127602-24-018711
SEC(opens sec.gov)
May 154
Galson Steven K0001127602-24-015369
SEC(opens sec.gov)
Jun 154
Galson Steven K0001127602-23-018788
SEC(opens sec.gov)
Jun 94
Galson Steven K0001127602-22-017141
SEC(opens sec.gov)
Sep 24
Galson Steven K0001127602-21-024770
SEC(opens sec.gov)
Jun 244
Vanda Pharmaceuticals Inc.0001209191-13-033403
SEC(opens sec.gov)
Jun 184
Galson Steven K0001209191-12-034334
SEC(opens sec.gov)
Jun 174
Galson Steven K0001209191-11-035330
SEC(opens sec.gov)
Jan 284/A
Galson Steven K0001209191-11-005547
SEC(opens sec.gov)
Jul 24
Galson Steven K0001209191-10-036807
SEC(opens sec.gov)

Companies

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703